DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy

NCT ID: NCT05905822

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

49 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-19

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will involve donating a salivary sample and a faecal (stool) sample. These will be analysed in the laboratory to determine the forms of the APOE gene you are carrying (your APOE genotype) and the response of the bacteria in your colon to reactive compounds extracted from edible plants (dietary bioactives).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In an ageing population, the incidence of dementia is rapidly increasing and poses a significant financial, societal, and above all, personal burden. Aside from ageing, the type of APOE gene an individual carries (their APOE genotype) is the greatest risk factor for the development of cognitive decline. It has been shown that the APOE genotype of an individual influences the types of bacteria present in the colon. The bacteria which reside in the colon have recently emerged as a significant contributor to nutrition and health and have been suggested to influence brain functioning through complex connections between the gut and the brain.

Nutrition is considered important for brain function throughout life, and findings from recent laboratory and human observational studies have suggested that reactive compounds extracted from edible plants (dietary bioactives) can not only improve brain function, but they can change the function and composition of gut bacteria. Dietary bioactives are a range of natural compounds found in great concentrations within fruits and vegetables which influence the body. An example of a dietary bioactive is a group of compounds known as polyphenols. These polyphenols are described as antioxidants and are found in various foods, including berries, tea, and cocoa.

There have been no previous studies looking at the impact of dietary bioactives on the microbiome of each APOE genotype and the metabolites produced by each of these bacteria. We aim with the current study to identify how dietary bioactives from a range of plant tissue could influence gut bacteria present and the metabolites produced by the bacteria in each APOE group, and the compounds produced by these bacteria.

What will the study involve? Once we have established a potentially suitable participant, they will be sent a salivary sampling kit. Depending on the genotype, age and sex, participants will be requested to donate a stool sample. The stool will be processed in a colon model with cocoa polyphenol added.

The study involves the following stages:

1. Online screening, consenting, and collection of basic information
2. Collection of a salivary sample in person at the Clinical Research Facility or home and return to the labs via pre-paid postal mail.
3. Confirmation of eligibility to donate stool samples.
4. Collection of stool samples on the same day as sample collection. Returning the sample in person or through the pre-paid postal system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prospectively genotyped participants

These participants will be advertised to in the local area. They will be genotyped for their APOE genotype, and then the stool sample will be collected.

No interventions assigned to this group

Database participants

Participants from the previously genotyped cohort "Early sleep and circadian markers of Alzheimer's disease: the impact of APOE-ε4 on circadian rhythm and sleep-wake homeostasis in humans" (Reference: 2017/18-135) who have consented to be contacted will be contacted to collect a stool sample.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 18-35 years old or aged 55+ years old
* Fluent in written and spoken English and capacity to consent
* Availability to take part in the study

Exclusion Criteria

* Participants will be excluded from donating if they have been diagnosed with any gastrointestinal conditions such as inflammatory bowel disease.
* They will also be excluded if they have a diagnosis of any form of dementia or severe cognitive impairment.
* They currently consume a high flavonoid intake defined as \>15 portions of flavonoid rich food per day.
* History or MRI evidence of brain damage, including significant trauma, stroke, learning difficulties or serious neurological disorder, including a loss of consciousness for more than 24 hours.
* Currently smoking or ceased smoking less than 6 months ago.
* Chronic fatigue syndrome, liver disease, diabetes mellitus, or gall bladder abnormalities.
* History of alcohol or drug dependency.
* Clinically diagnosed psychiatric disorder.
* Currently a participant or have been a participant in any other study involving an investigational product within the last 4 weeks.
* Received a COVID-19 diagnosis within the last 30 days
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Quadram Institute Bioscience

OTHER

Sponsor Role collaborator

University of East Anglia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Vauzour, PhD

Role: PRINCIPAL_INVESTIGATOR

University of East Anglia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Norwich and Norfolk University Hospital Clinical Research Facility

Norwich, Norfolk, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4.

Reference Type BACKGROUND
PMID: 36348357 (View on PubMed)

Seals RR Jr, Morrow RM, Kuebker WA. The dentist's role in Texas high school mouthguard programs. Tex Dent J. 1984 Oct;101(10):6-9. No abstract available.

Reference Type RESULT
PMID: 6593891 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

319832

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 NOT_YET_RECRUITING